Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical...
67 insider purchases on record · latest filing 2026-07-20.
Insiders have also filed 40 sale transactions at HQL.